VACBF (Nykode Therapeutics AS) Market Cap : $88.06 Mil (As of Dec. 15, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Nykode Therapeutics AS Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Nykode Therapeutics AS's share price for the quarter that ended in Sep. 2024 was $0.5191. Nykode Therapeutics AS's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 326.55 Mil. Therefore, Nykode Therapeutics AS's market cap for the quarter that ended in Sep. 2024 was $169.51 Mil.

Nykode Therapeutics AS's quarterly market cap declined from Mar. 2024 ($515.94 Mil) to Jun. 2024 ($489.82 Mil) and declined from Jun. 2024 ($489.82 Mil) to Sep. 2024 ($169.51 Mil).

Nykode Therapeutics AS's annual market cap stayed the same from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.00 Mil) but then increased from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($515.94 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Nykode Therapeutics AS's Enterprise Value for Today is $-29.22 Mil.

Nykode Therapeutics AS Market Cap Historical Data

The historical data trend for Nykode Therapeutics AS's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nykode Therapeutics AS Market Cap Chart

Nykode Therapeutics AS Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Market Cap

Get a 7-Day Free Trial

515.94

Nykode Therapeutics AS Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Market Cap	Get a 7-Day Free Trial															697.37	515.94	515.94	489.82	169.51

Competitive Comparison of Nykode Therapeutics AS's Market Cap

For the Biotechnology subindustry, Nykode Therapeutics AS's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nykode Therapeutics AS's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nykode Therapeutics AS's Market Cap distribution charts can be found below:

* The bar in red indicates where Nykode Therapeutics AS's Market Cap falls into.

Nykode Therapeutics AS Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Nykode Therapeutics AS's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )	=	Share Price (A: Dec. 2023 )	*	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	$1.58	*	326.546
	=	$515.94

Nykode Therapeutics AS's Market Cap for the quarter that ended in Sep. 2024 is calculated as

Market Cap (Q: Sep. 2024 )	=	Share Price (Q: Sep. 2024 )	*	Shares Outstanding (EOP) (Q: Sep. 2024 )
	=	$0.5191	*	326.546
	=	$169.51

Nykode Therapeutics AS (OTCPK:VACBF) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Nykode Therapeutics AS Market Cap Related Terms

Thank you for viewing the detailed overview of Nykode Therapeutics AS's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Nykode Therapeutics AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nykode Therapeutics AS (OTCPK:VACBF) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

NYKD:Norway 5VB:Germany

Address

Gaustadalleen 21, Oslo Research Park, Oslo, NOR, 0349

Website

https://www.nykode.com

Nykode Therapeutics AS is a clinical-stage biopharmaceutical company focused on the discovery and development of novel immunotherapies. The company is developing individualized cancer neoantigen vaccines and is using the Vaccibody technology to generate therapeutics to treat cancers with a high unmet medical need.